0.3321
Co Diagnostics Inc stock is traded at $0.3321, with a volume of 308.76K.
It is up +3.79% in the last 24 hours and down -1.36% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.3223
Open:
$0.335
24h Volume:
308.76K
Relative Volume:
0.01
Market Cap:
$20.27M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2407
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
+0.97%
1M Performance:
-1.36%
6M Performance:
+31.18%
1Y Performance:
-68.44%
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CODX
Co Diagnostics Inc
|
0.3328 | 19.63M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
126.31 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.20 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.80 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.44 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.05 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Can Co Diagnostics Inc. stock hit analyst price targets2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Will Co Diagnostics Inc. stock attract ESG investorsEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - The Herald Journal
Co-Diagnostics (NASDAQ: CODX) Details Co-Dx PCR MTB Test Plans for 30,000 India Clinics - Stock Titan
Developing predictive dashboards with Co Diagnostics Inc. dataDollar Strength & Fast Moving Stock Trade Plans - newser.com
Chart overlay techniques for tracking Co Diagnostics Inc.Earnings Recap Report & Daily Profit Maximizing Tips - newser.com
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com
Predicting Co Diagnostics Inc. trend using moving averagesWeekly Loss Report & Safe Capital Growth Tips - newser.com
Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
MSN Money - MSN
What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
Co-Diagnostics Inc. (CODX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dxtm PCR Platform to Support Submission to the U.S. FDA - Lelezard
Co-Diagnostics initiates clinical evaluations for upper respiratory multiplex point-of-care test on Co-Dx(TM) PCR platform to support submission to the U.S. FDA - MarketScreener
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - WV News
Sentiment analysis tools applied to Co Diagnostics Inc.July 2025 Volume & Community Consensus Picks - newser.com
What recovery options are there for Co Diagnostics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Co Diagnostics Inc. stock attractive after correctionEarnings Beat & Daily Market Momentum Tracking - newser.com
Will Co Diagnostics Inc. stock remain a Wall Street favoriteJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Is Co Diagnostics Inc. stock positioned well for digital economyDay Trade & Verified High Yield Trade Plans - Fundação Cultural do Pará
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2025 Earnings Call Transcript - Insider Monkey
What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Fundação Cultural do Pará
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... - Yahoo Finance
Co-Diagnostics Expands Global Reach and Innovates with AI - TipRanks
Why Co Diagnostics Inc. stock could rally in 2025Bond Market & Comprehensive Market Scan Insights - newser.com
Earnings call transcript: Co-Diagnostics Q3 2025 sees revenue drop, stock falls - Investing.com
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):